New drugs. Cheaper drugs. Why not both?

Why are American consumers paying out the wazoo for drugs? Drug companies say it's because they need that money to fund the research and development that goes into making new life-saving drugs. Today we talk to a health economist who says you actually can have it all, lower prices and more innovation.For sponsor-free episodes of The Indicator from Planet Money, subscribe to Planet Money+ via Apple Podcasts or at plus.npr.org.Learn more about sponsor message choices: podcastchoices.com/adchoicesNPR Privacy Policy

Om Podcasten

A bite-sized show about big ideas. From the people who make Planet Money, The Indicator helps you make sense of what's happening in today's economy. It's a quick hit of insight into money, work, and business. Monday through Friday, in 10 minutes or less.